Asset Details
Do you wish to reserve the book?
Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
Do you wish to request the book?
Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England
2025
Overview
A global increase in the incidence of invasive group A Streptococcus (iGAS) infections was observed after lifting of COVID-19 related restrictions in 2022, and type M1
dominated in many countries. After seasonal declines in iGAS incidence during the summer of 2023, simultaneous, rapid expansion of a previously rare emm type 3.93 was seen beginning in November, increasing to 20% of all cases in England and 60% of all cases in the Netherlands within 4 months. emm3.93 was associated with iGAS in children 6-17 years of age and with increased risk for pneumonia or pleural empyema and meningitis in both countries. No excess risk of death was identified for emm3.93 compared with other types. Genomic analysis of historic and contemporary emm3.93 isolates revealed the emergence of 3 new clades with a potentially advantageous genomic configuration. Our findings demonstrate the value of molecular surveillance, including long-read sequencing, in identifying clinical and public health threats.
Publisher
U.S. National Center for Infectious Diseases,Centers for Disease Control and Prevention
Subject
/ Adult
/ Analysis
/ Antigens, Bacterial - genetics
/ bacteria
/ Bacterial Outer Membrane Proteins - genetics
/ Child
/ Ethics
/ Female
/ Genomes
/ Humans
/ Identification and classification
/ Infant
/ Male
/ Patients
/ Streptococcal Infections - epidemiology
/ Streptococcal Infections - microbiology
/ Streptococcus pyogenes - classification
/ Streptococcus pyogenes - genetics
